Carregant...
Immune MAL2-practice: breast cancer immunoevasion via MHC class I degradation
The success of tumor immunotherapy, while partial, confirms the existence and importance of tumor immunosurveillance. CD8(+) T cell recognition of tumor-specific peptides bound to MHC class I (MHC-I) molecules is central to this process. In this issue of the JCI, Fang, Wang, et al. describe a unique...
Guardat en:
| Publicat a: | J Clin Invest |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Clinical Investigation
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7773378/ https://ncbi.nlm.nih.gov/pubmed/33393509 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI144344 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|